To determine whether or not broad-spectrum deacetylase inhibitors can be found, we have designed a new class of hydroxamate-containing inhibitors of LpxC, starting with the structure of the physiological substrate. Several of these compounds inhibit both E. coli and A. aeolicus LpxC at similar concentrations. We have also identified a phosphinate-containing substrate analog that inhibits both E. coli and A. aeolicus LpxC, suggesting that the LpxC reaction proceeds by a mechanism similar to that described for other zinc metalloamidases, like carboxypeptidase A and thermolysin. The differences between the phenyloxazoline and the substrate-based LpxC inhibitors might be exploited for developing novel antibiotics targeted either against some or all Gram-negative strains. We suggest that LpxC inhibitors with antibacterial activity be termed "deacetylins."
Lipid A from Escherichia coli and Salmonella typhimurium consists of a ␤,1Ј-6-linked disaccharide of glucosamine that is phosphorylated at the 1-and 4Ј-positions and is derivatized with up to seven fatty acyl chains (1) (2) (3) (4) (5) . All of the enzymes that synthesize lipid A and the genes encoding them have been identified in E. coli (3, 6) . Single copy genes encoding homologues of the E. coli lipid A enzymes are also found in most other sequenced Gram-negative organisms. The biosynthesis of lipid A is essential for E. coli growth (7) (8) (9) (10) (11) , possibly because it is required for outer membrane protein folding (12) , and lipid A is unique to Gram-negative outer membranes. The enzymes of lipid A biosynthesis are therefore ideal targets for the development of new antibiotics (10) . With the recent re-emergence of antibiotic-resistant bacteria (13, 14) , there is an urgent need for drugs that act on targets different from those inhibited by the available antibiotics.
The second and committed enzyme of lipid A biosynthesis in E. coli (LpxC) 1 catalyzes the N-deacetylation of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine, yielding a free amino group that is immediately acylated with another R-3-hydroxymyristoyl chain by LpxD (Scheme 1) (8, 15, 16) . The LpxC deacetylase has been purified and characterized from both E. coli and Pseudomonas aeruginosa (17, 18) . The two proteins display 57% identity and 79% similarity over their entire length (19) . E. coli LpxC contains a bound zinc ion that is required for catalytic activity (20) . Chiral phenyloxazolinebased hydroxamates (Fig. 1) , which are presumed to coordinate the active site metal of LpxC, have recently been described (10) . Some of these compounds display significant antibacterial activity against E. coli cells, but they are not active against P. aeruginosa (10) . P. aeruginosa LpxC is ϳ20 times more resistant to the phenyloxazoline-based inhibitors than is E. coli LpxC (see below). Despite the limitations in the spectrum of the available inhibitors, the zinc ion-dependent mechanism of LpxC is very attractive from the perspective of medicinal chemistry, since extraordinarily potent inhibitors of other zinc metalloamidases have been described, including the blood pressure-lowering drugs captopril and enalapril (21, 22) . The question of whether deacetylase inhibitors could be designed that effectively inhibit LpxCs from all Gram-negative bacteria has not been explored.
The recent publication of the complete genome sequence of the hyperthermophilic Gram-negative bacterium Aquifex aeolicus (23) affords a unique opportunity to study a thermostable LpxC variant that might be amenable to x-ray crystallography studies. A. aeolicus grows at 95°C, making it one of the most thermophilic bacteria yet described (23) . As an obligate chemilithoautotroph, it grows in an atmosphere of hydrogen, carbon dioxide, and oxygen, solely in the presence of inorganic salts (23, 24) . From a comparison of 16 S rRNA sequences, A. aeolicus is one of the earliest diverging eubacteria on the evolutionary tree (23) . This observation is consistent with the fact that A. aeolicus LpxC is the least homologous to E. coli LpxC (32% identity and 51% similarity over 277 amino acid residues) of the ϳ30 LpxCs identified so far (19) . Therefore, a comparison of A. aeolicus LpxC and E. coli LpxC might reveal conserved mechanistic features and facilitate the design of broad-spectrum LpxC inhibitors.
We now report the cloning, overexpression, and purification to homogeneity of LpxC from A. aeolicus. This hyperthermophilic enzyme efficiently deacetylates the physiological E. coli LpxC substrate UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine at 30°C. However, A. aeolicus LpxC is optimally active at much higher temperatures (70°C) than is the E. coli enzyme (40°C). Interestingly, the phenyloxazoline-based hydroxamates that are potent inhibitors (K i ϳ50 nM) of the E. coli deacetylase (10) have no activity against A. aeolicus LpxC, even at concentrations as high as 1 mg/ml (3-5 mM). We have therefore designed a new class of LpxC inhibitors that incorporate part of the structure of the natural substrate. Some of these new inhibitors are equally active against A. aeolicus, E. coli, and P. aeruginosa LpxCs, with IC 50 values in the low micromolar range. These inhibitors should serve as leads for the development of novel antibiotics with activity against the entire spectrum of Gram-negative organisms.
MATERIALS AND METHODS

Buffers and Reagents-[␣-
32 P]UTP was purchased from NEN Life Science Products. Polyethyleneimine-cellulose TLC plates were obtained from E. Merck (Darmstadt, Germany). Bis-tris buffer (Ultrapure reagent) and bovine serum albumin (BSA), essentially fatty acidfree, were purchased from Sigma. Restriction enzymes were purchased from New England Biolabs, and Pfu DNA polymerase was from Stratagene. Deacetylase inhibitor L-573,655 was obtained from Dr. A. Patchett (Merck) (10) . The substrate analog LpxC inhibitors TU-514, TU-517, TU-521, TU-519, and 6SHT55 were synthesized in the Department of Chemistry at the University of Alberta with the support of Glycobiotics Inc. (Athens, GA) (39) and will be described in detail in a subsequent paper. The R,S and S isomers of L-161,240 (10) were synthesized in the Department of Chemistry at Duke University by minor modifications of published procedures (25) .
Cloning of A. aeolicus lpxC-The A. aeolicus lpxC gene was identified by a BLASTp search (19) using the E. coli LpxC sequence against the complete genome sequence of A. aeolicus (23) . Primers were designed to the N-and C-terminal regions of the A. aeolicus lpxC gene (5Ј-CTGA-CAGGATCCAATTCAGAGAGCTTGGACGG-3Ј and 5Ј-CGAGCAGCG-CATATGGGATTAGAAAAGACGG-3Ј, respectively). These primers were used in a polymerase chain reaction containing genomic A. aeolicus DNA (50 -100 g) as the template, kindly provided by Dr. Karl O. Stetter (23) . A. aeolicus lpxC was amplified using Pfu DNA polymerase (according to the manufacturer's specifications) in a 100-l reaction mixture containing a 0.2 M concentration of each dNTP and 0.5 M concentration of each primer for 25 polymerase chain reaction cycles (95°C denaturation, 55°C annealing, 72°C polymerization). The polymerase chain reaction product was digested with BamHI and NdeI restriction enzymes at positions introduced by the primer sequences. A band of the correct size predicted for the digested lpxC gene was purified by gel electrophoresis and ligated into the T7 expression vector, pET21a (Novagen), that had been cut in the multiple cloning site with the same enzymes. The final DNA sequence of the cloned lpxC gene in the plasmid, pAaLpxC, was confirmed to match the published sequence exactly (23) , and this construct was used for the expression and purification of the A. aeolicus LpxC protein.
A matched expression plasmid containing the E. coli lpxC gene in the pET21a background was constructed by excising E. coli lpxC from the SCHEME 1. Role of the LpxC deacetylase in the biosynthesis of UDP-2,3-diacylglucosamine and lipid A. The glucosamine residues of lipid A are derived from UDP-N-acetylglucosamine (1, 3, 37) . The LpxC deacetylase catalyzes the committed reaction (second step) of lipid A biosynthesis, since the LpxA-catalyzed acylation of UDP-N-acetylglucosamine is reversible (38) . pET11a-envA expression plasmid (17) using the BamHI and NdeI restriction sites. The E. coli lpxC gene was then ligated into pET21a that had been digested with the same restriction enzymes, and the resulting plasmid, pEcLpxC, was sequenced to verify that it contained the correct E. coli lpxC sequence.
Expression of Active A. aeolicus LpxC-The plasmids pET21a, pAaLpxC, and pEcLpxC were transformed into BL21(DE3)pLysS cells (26) . Cultures were prepared by growing single colonies of these three strains overnight in LB broth supplemented with 50 g/ml ampicillin and 30 g/ml chloramphenicol at 37°C. The overnight cultures were then used to inoculate two fresh 50-ml cultures consisting of rich induction medium (27) for each strain; these were grown at 34°C to A 620 ϭ 0.4 -0.5. At this point, 1 M isopropyl-␤-D-thiogalactopyranoside and 100 M ZnSO 4 were added to one of the two cultures of each strain in order to induce LpxC expression. After being grown in parallel for an additional 3 h at 34°C, the induced and uninduced cells were harvested by centrifugation at 6000 ϫ g for 15 min at 4°C. The cell pellets were washed by resuspension in 15 ml of 25 mM Hepes buffer, pH 7, containing 20% glycerol and 0.2 mM dithiothreitol (DTT), and the cells were collected by centrifugation at 6000 ϫ g for 10 min as above. The washed cells were resuspended in 5 ml of the same buffer with DTT at 2 mM and were broken using a French pressure cell at 18,000 p.s.i. Cell-free crude extracts were made by centrifugation of the lysates at 2000 ϫ g for 20 min. Total protein concentrations of the extracts were determined using the BCA procedure (28) (8, 20) . Initial rates of LpxC-catalyzed deacetylation of this substrate were determined using crude extracts of E. coli containing pET21a (0.2 mg/ml), pAaLpxC (0.1-1.0 g/ml), or pEcLxpC (1.0 g/ml). These assays were performed at temperatures ranging from 1 to 80°C, as indicated, and contained 3 M [␣-
6 cpm/nmol), 1 mg/ml BSA, and 0.5 mM AMP. The buffer used for these assays was 40 mM bis-tris, pH 5.9, when measured at 30°C. The pH of this buffer does change slightly as a function of temperature, from pH 6.2 when measured at 1°C to pH 5.5 when measured at 60°C. However, this does not affect the qualitative interpretation of the assay results. The activity assays were performed in plastic microcentrifuge tubes in a reaction volume of 20 l. At each time point (chosen so that the total conversion to product was less than 10%), 5-l portions of each reaction mixture were removed and added to 1 l of 1.25 M NaOH to stop the reaction. The base-treated samples were incubated for an additional 10 min at 30°C to ensure complete hydrolysis of the esterlinked acyl chains from the LpxC substrate and product and then were neutralized by the addition of 1 l of 1.25 M acetic acid and 1 l of 5% trichloroacetic acid. The neutralized samples were incubated on ice for 5 min and centrifuged for 2 min in a microcentrifuge. Portions of the supernatants (2 l) were spotted onto PEI-cellulose TLC plates for separation of the remaining substrate (detected as [␣-
32 P]UDP-GlcNAc) from the product (detected as [␣-
32 P]UDP-GlcN). After air drying, the plates were washed for 5 min with methanol before chromatography to improve resolution. The plates were then developed with 0.2 M aqueous guanidine-HCl as the solvent system. The radioactive spots on the plates were analyzed using a PhosphorImager equipped with ImageQuant software (Molecular Dynamics, Inc., Sunnyvale, CA) to determine the yields of product produced in each reaction mixture.
A. aeolicus LpxC activity assays with the purified protein were performed in essentially the same way, except that the 0.5 mM AMP was omitted. Steady-state kinetic parameters and S.E. values for the deacetylation of [␣- Purification of A. aeolicus LpxC-Three liters of rich induction medium (27) were inoculated with 100 ml of an overnight culture of BL21(DE3)/pLysS/pAaLpxC and grown at 34°C to A 620 ϭ 0.4 -0.5. At this point, expression of A. aeolicus LpxC was induced by the addition of 1 mM isopropyl-␤-D-thiogalactopyranoside and 0.1 mM ZnSO 4 . After 6 h, the cells were harvested, and the resulting 20 g of wet cell paste was resuspended in 83 ml of 10 mM sodium phosphate buffer, pH 6.2, containing 2 mM DTT and frozen in two batches at Ϫ80°C. Each batch was processed separately at 4°C. The resuspended cell pellet was lysed by passage through a French pressure cell at 18,000 p.s.i. The cellular debris was removed by ultracentrifugation in a Beckman Ti-50.2 rotor at 40,000 rpm for 60 min. The supernatant from this step (34 ml) was diluted 3-fold with 25 mM Hepes, pH 7.0, containing 2 mM DTT and loaded onto a 75-ml DEAE-Sepharose anion exchange column, equilibrated in the same buffer. The column was washed with 125 ml of 25 mM Hepes, pH 7.0, containing 2 mM DTT and 0.1 M KCl. Most of the A. aeolicus LpxC protein was then eluted in a single step consisting of 50 ml of 25 mM Hepes, pH 7.0, containing 2 mM DTT and 0.3 M KCl. This fraction was dialyzed against 25 mM Hepes, pH 7.0, containing 2 mM DTT, and then diluted to approximately 80 ml with the same buffer. The dialyzed sample was loaded at 0.5 ml/min onto a Q-Sepharose Fast-Flow (Amersham Pharmacia Biotech) FPLC column (HR16/10, 20 ml) that had been equilibrated in 25 mM Hepes, pH 7.0, containing 2 mM DTT. After loading the protein, the column was washed with an additional 40 ml of the equilibration buffer, and then a linear gradient (500 ml) of 0 -0.3 M KCl in 25 mM Hepes, pH 7.0, containing 2 mM DTT was used to elute the column. LpxC emerged in a sharp peak at 0.12-0.13 M KCl. This protein was desalted and concentrated to about 8 ml using an Amicon ultrafiltration apparatus, and the resulting protein was loaded onto a Sephacryl-200 HiPrep (S-200 26/10; Amersham Pharmacia Biotech) gel filtration column in two separate batches of 4 ml each. The S-200 column was pre-equilibrated and eluted in 50 mM bis-tris buffer, pH 6.0, containing 150 mM NaCl at 1 ml/min. The LpxC activity and protein eluted from this column in a single peak and were judged to be ϳ90 -95% pure by SDS-polyacrylamide gel electrophoresis. The concentration of total protein at each step was measured using the BCA protein assay (Pierce) with BSA as the standard (28) . Purified protein was stored at Ն1 mg/ml in 50 mM bis-tris, pH 6.0 buffer, containing 150 mM NaCl and frozen at Ϫ80°C. Electrospray mass spectrometry (Duke University Mass Spectrometry Facility, Research Triangle Park, NC) showed that the LpxC purified in this manner was homogeneous, with a predicted molecular weight of 32013 Ϯ 3, corresponding to the predicted molecular weight of A. aeolicus LpxC with the N-terminal fMet residue removed.
Inhibition of LpxC Activity-Purified E. coli LpxC (20) and purified A. aeolicus LpxC were used for characterizing inhibitors. Stock solutions (10 mg/ml) of each inhibitor were made in 100% Me 2 SO, and any further dilutions of these compounds were also made in 100% Me 2 SO. E. coli LpxC (5 nM) or A. aeolicus LpxC (7.8 nM) was incubated with varied concentrations of each inhibitor in the presence of 1 mg/ml BSA and 10% Me 2 SO, for 20 -40 min on ice prior to starting the assays. The LpxC/inhibitor stocks were then diluted 2.5-fold into assay mixtures containing 3 mM UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine in 40 mM bis-tris, pH 5.5, at 30°C, to give a final enzyme concentration of 2 nM E. coli LpxC or 3.1 nM A. aeolicus LpxC. Assay tubes were supplemented with each of the inhibitors and additional Me 2 SO, if necessary, to maintain the same concentration of the inhibitor and Me 2 SO in the assay as was present in the preincubation with enzyme. The initial velocities were plotted as a function of inhibitor concentration for each compound. The resulting data were fit to Equation 1 as follows,
where v i represents the initial velocity at a given concentration of inhibitor and v c represents the initial velocity of a control reaction containing no inhibitor, to yield the IC 50 for inhibition at 30°C by each compound.
The K i values for inhibition of E. coli LpxC by three of the most potent inhibitors (LNTI-229, TU-514, and TU-517) were determined using the same assay conditions (40 mM bis-tris, pH 5.5, at 30°C) at varied substrate concentrations (1-10 M). The initial velocities measured at each concentration of inhibitor (0 -500 nM for LNTI-229 and 0 -11 M for TU514 and TU-517) and substrate were fit simultaneously to Equation 2 using the Systat data analysis software (version 5.2; Systat, Inc.) in order to determine the K i for LpxC inhibition.
Disc Diffusion Test for Antibacterial Activity of LpxC Inhibitors-A 5-ml culture of E. coli strain R477 (7) was grown to stationary phase at 37°C in LB broth containing 30 g/ml streptomycin. This culture was diluted with LB broth (29) to A 620 ϭ 0.2, and then a sterile cotton swab was used to spread an even lawn of the diluted culture onto an LB agar plate. Filter paper discs (6-mm diameter) were saturated with 50 g of the compound (in 100% Me 2 SO) to be tested for antibacterial activity. The discs were placed on the lawn of freshly plated cells, and the plates were then incubated at 37°C. Inhibition of bacterial growth was detected as a zone of clearing around each disc. The diameter of the zone of growth inhibition was measured for each compound after overnight incubation. A diameter of 6 mm indicated that there was no visible inhibition of growth beyond the edges of the disc.
RESULTS
Cloning and Expression of Active A. aeolicus LpxC-Using
the BLASTp protein search algorithm (19), we identified a distantly related homologue (32% identity and 51% similarity over 277 amino acids) to E. coli LpxC (17) in the genomic sequence of A. aeolicus. We cloned the A. aeolicus lpxC gene into the pET21a expression plasmid behind an inducible T7 RNA polymerase promoter to direct overexpression of A. aeolicus LpxC in E. coli following treatment with isopropyl-␤-Dthiogalactopyranoside (26) . A band of approximately the correct molecular mass, as expected for A. aeolicus LpxC (32,150 Da), was identified in induced cell-free extracts (data not shown). When assayed for LpxC activity at 30°C using the E. coli LpxC substrate UDP-3-O-(R-3-hydroxymyristoyl)-Nacetylglucosamine, extracts made from cells containing the A. aeolicus LpxC plasmid, pAaLpxC, exhibited a 100-fold increase in LpxC activity upon induction (Table I) , whereas extracts of cells containing the E. coli LpxC plasmid, pEcLpxC, exhibited a ϳ5000-fold stimulation under the same conditions. However, when the assay temperature was raised to 60°C, the stimulation of A. aeolicus LpxC activity upon induction was much more pronounced (ϳ10 5 -fold). The observed increase in activity was dependent upon the presence of the LpxC-containing plasmid; the cell-free extracts from the pET21a vector-containing cells exhibited only background levels of LpxC activity due to endogenous E. coli deacetylase encoded by the chromosomal lpxC gene (Table I ). The temperature dependence of LpxC activity in extracts made from induced E. coli cells containing either pAaLpxC or pEcLpxC demonstrates that A. aeolicus LpxC is active at much higher assay temperatures than is E. coli LpxC (Fig. 2) . A. aeolicus LpxC activity measured in vitro reaches a maximum level at 70°C, whereas the temperature optimum of the in vitro E. coli LpxC reaction is 40°C.
Purification of A. aeolicus LpxC-To characterize the A. aeolicus LpxC enzyme and compare it to the well-studied E. coli enzyme, we purified A. aeolicus LpxC to near homogeneity using a combination of anion exchange and gel filtration chromatography. Like the E. coli enzyme, A. aeolicus LpxC adheres to anion exchange resins, such as DEAE-Sepharose and QSepharose, and it can be eluted with buffers containing KCl. This property was exploited to attain a 5-fold purification (Table II). A. aeolicus LpxC was then further purified on an S-200 gel filtration column, yielding a final preparation with 6.9-fold higher specific activity than the initial cell lysate. The SDSpolyacrylamide gel electrophoresis analysis of the purified A. aeolicus LpxC (Fig. 3) demonstrates that the preparation is about 90 -95% homogeneous. The concentration of purified A.
aeolicus LpxC was determined using the BCA protein assay with BSA as the standard.
Steady-state Kinetic Parameters-A. aeolicus LpxC activity depends upon the concentration of the substrate, UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine, in a manner that is well described by the Michaelis-Menten equation at both 30 and 60°C. The k cat /K m for catalysis by A. aeolicus LpxC increases with increasing temperature, similar to what is seen with E. coli LpxC when the assay temperature is increased from 1 to 30°C (Table III) . The k cat /K m values for both enzymes near their optimal assay temperatures are almost identical, and at ϳ10 6 M Ϫ1 s Ϫ1 , they are well below the limit for a diffusion-controlled enzymatic reaction (ϳ10 (30) . A. aeolicus LpxC also resembles E. coli LpxC in that 1 mg/ml BSA is required in the assay to maintain optimal catalytic activity at low enzyme concentrations (below 10 M) (20) . At 2-5 nM enzyme, assays in the absence of BSA showed no measurable LpxC activity (data not shown). The function of BSA in the assay at low enzyme concentrations is unknown (20) . (Fig. 1) . The racemic form of L-161,240 (designated LNTI-229) (Fig. 1 ) was synthesized by a modification of the published procedures (10, 25) . Inhibition of A. aeolicus and E. coli LpxC activity by 0.1 mg/ml L-573,655 or LNTI-229 was measured at 30°C in assays containing purified enzyme (3.1 nM for A. aeolicus LpxC or 2 nM for E. coli LpxC) together with 3 M UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc in 40 mM bis-tris buffer, pH 5.5. Under these conditions, L-573,655 and LNTI-229 both inhibit E. coli LpxC, with 7.0 and 0.2% of activity remaining, respectively, compared with an uninhibited control reaction. However, neither of these compounds inhibited purified A. aeolicus LpxC under these conditions. No inhibition of A. aeolicus LpxC activity could be observed even at concentrations of L-573,655 or LNTI-229 as high as 1 mg/ml in the assays (data not shown). Also, A. aeolicus LpxC was not inhibited by either of these compounds when assayed closer to its optimal temperature for activity at 60°C. Based on these results, 
aeolicus and E. coli LpxC activity in extracts of E. coli BL21(DE3)pLysS
Specific activity of extracts of E. coli containing the indicated plasmid were assayed for LpxC activity with 3 M UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc in 40 mM bis-tris, pH 5.9, 30°C or pH 5.5, 60°C. Reactions also contained 0.5 mM AMP to inhibit CDP-diglyceride hydrolase (3) and 1 mg/ml BSA. Assays of the uninduced cell extracts, and the induced pET21a/BL21(DE3)pLysS cell extract were performed using 0.2-0.4 mg/ml extract. Assays with the induced pEcLpxC and pAaLpxC extracts were performed using 0.01 g/ml extract. were used as the source of enzyme in activity assays at the indicated temperatures (1-80°C). Solutions of LpxC-expressing extracts (2.5 g/ ml) containing 1 mg/ml BSA in 40 mM bis-tris, pH 5.9 (when measured at 30°C; see "Materials and Methods"), were incubated for 3 min at the indicated assay temperatures before initiation of each reaction. Reactions were started by 2.5-fold dilutions of enzyme into an assay mixture containing 3 M UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine and 0.5 mM AMP in 40 mM bis-tris, pH 5.5, for a final extract concentration of 1 g/ml in each assay.
LNTI-229 is at least 10 4 -fold weaker as an inhibitor of A. aeolicus LpxC than of E. coli LpxC.
Inhibition by Substrate Analogs Containing Hydroxamate Moieties-The phenyloxazoline compounds L-573,655 and LNTI-229 (Fig. 1) require the presence of the hydroxamate functional group for inhibition of E. coli LpxC (10) . In an attempt to find inhibitors with activity against the complete spectrum of Gram-negative LpxCs, a new class of compounds was synthesized that incorporate the hydroxamate functional group into substructures of the physiological LpxC substrate (Fig. 4) . These potential LpxC inhibitors contain a tetrahydropyran ring with the hydroxamate group appended at the position analogous to the location of the N-acetyl group in the LpxC substrate (Fig. 4) . The IC 50 values for inhibition by these compounds against the purified LpxC enzymes from E. coli and A. aeolicus were determined at 30°C, using 3 M UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine, a concentration of substrate that is around the K m for both enzymes (Fig. 5 and Table IV ). Inhibition by the most potent LpxC inhibitors, TU-514 and TU-517, was not time-dependent; the observed inhibition was complete within the time required to start assays containing 0.01 mg/ml of each inhibitor (about 10 s, data not shown). In routine assays, however, reactions were initiated with enzyme that had been preincubated with inhibitor for 20 -40 min on ice. The best of the hydroxamate-containing substrate analogs (TU-514 and TU-517) exhibit IC 50 values for both the A. aeolicus and the E. coli LpxC that are in the low micromolar range when assayed at 30°C under the same conditions ( Fig. 5 and Table IV) .
Substrate analog inhibitors were prepared with alternative acyl chains attached at the position corresponding to the glucosamine 3-OH on the E. coli LpxC substrate (Fig. 4) . Inhibition of both E. coli and A. aeolicus LpxC is dependent upon the presence and length of the acyl substituent, as indicated by the increasing IC 50 values observed for the compounds TU-514, TU-517, TU-521, and TU-519 (Fig. 4 and Table IV ). Inhibition of E. coli LpxC gradually decreases as the acyl chain is decreased from 14 to 6 to 0 carbon atoms. Inhibition of A. aeolicus LpxC exhibits a steeper dependence on the length of the acyl chain; inhibitory activity completely disappears as the acyl chain is shortened to a 6-carbon unit in the hydroxyamate series. Inhibition of A. aeolicus LpxC is slightly better with the nonhydroxylated C 14 fatty acyl substituent in TU-514, whereas inhibition of E. coli LpxC is optimal with the hydroxylated C 14 fatty acyl moiety in TU-517 (Fig. 4 and Table IV) . TU-514 and TU-517 also inhibit P. aeruginosa LpxC with IC 50 values similar to those observed against the E. coli enzyme (data not shown). Additional substrate analogs were synthesized with ketone, carboxylate, or trifluoromethyl ketone groups in place of the hydroxamate moiety (structures not shown). None of these compounds potently inhibited either of the LpxC enzymes, even at concentrations as high as 1 mg/ml (data not shown). However, the phosphinate-containing substrate analog 6SHT55 (Fig. 4) (Table IV) . Inhibition by 6SHT55 was not found to be time-dependent within the interval required to start the LpxC assay (data not shown). For E. coli LpxC, the C 6 -containing phosphinate 6SHT55 is not as active as the C 6 -containing hydroxamate compound TU-521 (Fig. 4) , suggesting that the hydroxamates are better inhibitors of E. coli LpxC than the phosphinates in this series of analogs. However, when tested in assays with A. aeolicus LpxC, the phosphinate-containing 6SHT55 is a much better inhibitor than the comparable hydroxamate TU-521 (Fig. 4 and Table  IV (Figs. 1 and 4) . We demonstrated that LNTI-229 acts as a competitive inhibitor of E. coli LpxC, with K i ϭ 104 Ϯ 19 nM (Fig. 6) , consistent with the previous extrapolation of 50 nM for L-161,240 (the R-enantiomer of LNTI-229), which was estimated from the K i of L-573,655 and the IC 50 of L-161,240 (10) . Using the same conditions used for the K i determination for LNTI-229, we found that TU-514 and TU-517 are also competitive inhibitors of E. coli LpxC, with K i values of 650 Ϯ 280 nM for TU-514 and 190 Ϯ 50 nM for TU-517. Importantly, the S-enantiomer of LNTI-229 is ϳ250 times less potent as an inhibitor of the deacetylase (data not shown).
Antibacterial Activity of LpxC Inhibitors-The antibacterial a Specific activity was determined using 3 M substrate in assays containing 1 mg/ml BSA, 40 mM bis-tris, pH 5.5, at 60°C. b Overall yield was calculated to take into account processing of the sample in several batches.
activities of the three most potent inhibitors of E. coli LpxC against the E. coli K-12 strain R477 were assessed using antibiotic susceptibility disc tests. As a control, the effect of the pure S-enantiomer of LNTI-229 on the growth of E. coli R477 was measured and compared with that of the racemic inhibitor LNTI-229. A large zone of inhibition was observed surrounding a disc containing 50 g of the LNTI-229, whereas there was no detectable inhibition of growth surrounding a disc containing 50 g of the pure S-enantiomer (Fig. 7 , discs 1 and 2, respectively). No inhibition of bacterial growth beyond the 6-mm paper disc was observed with the same amount (50 g) of L-573,655 against E. coli R477 (Fig. 7, disc 4) . For comparison, a disc containing 25 g of the antibiotic ampicillin was also tested (Fig. 7, disc 3) . Inhibition of E. coli growth by LNTI-229 is almost comparable with that observed with ampicillin under these conditions, consistent with previous determinations of the minimal inhibitory concentration (10) . Despite the significant potency of TU-514 and TU-517 (K i values of 650 Ϯ 280 and 190 Ϯ 50 nM, respectively) against E. coli LpxC in vitro, neither TU-514 nor TU-517 inhibited the growth of E. coli R477 in the antibacterial disc test (data not shown). The presence of the fatty acyl chain in TU-514 and TU-517 may limit the ability of these compounds to cross the cell envelope of E. coli (Fig. 4) . However, some antibacterial activity is detected with TU-514
against an E. coli R477 mutant strain harboring a single amino acid substitution in LpxC (10), which renders the cells several orders of magnitude more sensitive to all deacetylase inhibitors (data not shown).
DISCUSSION
In the present study, we have cloned, overexpressed, and purified to homogeneity LpxC from A. aeolicus, a Gram-negative hyperthermophile that is among the most divergent of the eubacteria sequenced to date (23) . The temperature profiles of the activities of E. coli and A. aeolicus LpxC are similar in shape but are shifted from one another by ϳ30°C (Fig. 2) . This finding is consistent with the fact that A. aeolicus grows at very high temperatures. In fact, since A. aeolicus is able to grow at temperatures up to 95°C, the decrease in activity observed when the extracts were assayed above 70°C was unexpected, but it may have been caused by contaminating E. coli proteins or precipitation of BSA at high temperatures. Nevertheless, the inherent stability of the A. aeolicus enzyme (Fig. 2) should facilitate efforts to determine the three-dimensional structure of LpxC.
The E. coli LpxC substrate (16, 20) , UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine (Scheme 1), is an excellent substrate for A. aeolicus LpxC. In fact, the k cat /K m values for these two enzymes near their optimal temperatures in vitro are nearly identical (Table III) . For both enzymes, k cat /K m increases with increasing temperature as the optimum is approached. For A. aeolicus LpxC, this increase is due to an increase in the steady-state k cat value as well as to a decrease in the steady-state K m for UDP-3-O-(R-3-hydroxymyristoyl)-Nacetylglucosamine. The very similar kinetic parameters suggest that the E. coli LpxC substrate may be very close in structure to the physiologically relevant substrate for A. aeolicus LpxC. Recent studies (40) of the structure of lipid A of A. aeolicus support this hypothesis. These studies have shown that the mature A. aeolicus lipid A contains predominantly hydroxymyristate residues at the 3-and 3Ј-positions, as would be expected if UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine (or something very similar) is the natural A. aeolicus substrate. Interestingly, the lipid A disaccharide of A. aeolicus consists of 2,3-dideoxy-2,3-diaminoglucose instead of glucosamine, 2 suggesting that LpxC of A. aeolicus normally deacetylates a substrate in which the acyl chain at position 3 is N-linked.
Previously, screens for compounds that inhibit bacterial growth by blocking lipopolysaccharide biosynthesis led to the identification of LpxC inhibitors that contained a hydroxamate group attached to a phenyloxazoline scaffold (Fig. 1) (10) . These findings suggested that LpxC might be a zinc metalloenzyme. Indeed, 1-2 mol of zinc are present per mol of purified LpxC, and zinc or cobalt ions are able to reactivate the inactive E. coli apo-LpxC (20) . The hydroxamate inhibitors probably interfere 2 O. Holst, personal communication. a Initial rates of deacetylase activity were determined using purified A. aeolicus LpxC in the standard LpxC activity assay at each temperature. Assays contained 1 mg/ml BSA in 40 mM bis-tris, pH 5.5, and either 3.1 nM enzyme and 0.5-30 M substrate (30°C) or 1.6 nM enzyme and 0.25-10 M substrate (60°C).
b Steady-state kinetic parameters for E. coli LpxC are taken from Jackman et al. (20) .
FIG. 4. Structures of substrate analog inhibitors.
Structures of the various hydroxamate-and phosphinate-based substrate analogs tested in Table IV are shown. The structure of the E. coli LpxC substrate is the same as that shown in Scheme 1.
with LpxC activity by chelating the active site zinc ion, in a manner similar to that observed with other zinc metalloenzymes, such as thermolysin (31) and angiotensin-converting enzyme (21, 32) . In support of this hypothesis, the recent crystal structure of an A. aeolicus protein homologous to eucaryotic histone deacetylases (although not to the LpxC deacetylase family) reveals the presence of a single zinc ion (33) . Moreover, the specific hydroxamate-containing inhibitors trichostatin A and suberoylanilide hydroxamic acid coordinate the zinc ion in a similar manner as observed with other metalloamidases (33) .
An unexpected finding of the present study was the inability of the phenyloxazoline-based hydroxamates to inhibit A. aeolicus LpxC. We therefore synthesized a new series of compounds more closely related to the structure of the LpxC substrate (Fig.  4) and demonstrated that these compounds inhibit A. aeolicus, E. coli, and P. aeruginosa LpxC with comparable potency. Inhibitors containing a hydroxamate moiety at the position analogous to that occupied by the reactive N-acetyl group in the physiological LpxC substrate (Fig. 4) inhibit LpxC with IC 50 values in the low micromolar range (Table IV) . As with the phenyloxazoline-based inhibitors (10) , replacement of the hydroxamate functional group with either a carboxylate or a ketone moiety results in the complete loss of inhibition against either E. coli or A. aeolicus LpxC (data not shown). Furthermore, as had been observed both with the native substrate and the phenyloxazoline inhibitors of E. coli LpxC, the hydrophobic substituents are important for effective catalysis (20) or inhibition (10), respectively. As the length of the acyl chain attached to the position in the substrate-based inhibitors corresponding to the GlcNAc 3-OH of the LpxC substrate is decreased (Fig. 4) , the IC 50 for inhibition of LpxC increases (Table IV) . Despite the fact that the 14-carbon hydroxamates (Fig. 5) , as described under "Materials and Methods." A. aeolicus LpxC was used at 3.1 nM in assays containing 3 M substrate and 1 mg/ml BSA in 40 mM bis-tris, pH 5.5, at 30°C. The IC 50 for inhibition of E. coli LpxC at 30°C was determined using 2 nM enzyme with 3 M substrate and 1 mg/ml BSA in 40 mM bis-tris, pH 5.5. The IC 50 measurements at 1°C were made using 0.1 M enzyme, 4 M substrate ([S] ϳ K m ), and 1 mg/ml BSA in 40 mM bis-tris, pH 5.7.
b Lower limit of IC 50 determined based on lack of inhibition observed with up to 1 mg/ml inhibitor in the assays.
c Not determined. TU-514 and TU-517 inhibit A. aeolicus and E. coli LpxC to a similar extent (Fig. 5) , inhibition of A. aeolicus LpxC is somewhat more dependent upon the hydrophobic character of the 3-O-acyl substituent of the inhibitor (Table IV) . Even decreasing the length of the acyl chain to 6 carbons increases the IC 50 Ͼ200-fold, resulting in the loss of any detectable inhibition of the A. aeolicus enzyme (Table IV) .
Many zinc metalloamidases, including thermolysin, carboxypeptidase A and collagenase, are potently inhibited by compounds that contain a phosphonate functional group (22, 34) . Crystal structures of the phosphonamidate compound carbobenzoxy-Phe(P)-Leu-Ala (K i ϭ 68 pM) complexed with the zinc metalloprotease thermolysin, show that these inhibitors act as mimics of the proposed tetrahedral transition state in catalysis and also coordinate the active site zinc ion (34, 35) . We therefore synthesized and demonstrated that a substratebased compound (6SHT55) containing a phosphinate moiety at the position of the reactive N-acetyl group inhibits both E. coli and A. aeolicus LpxC (Fig. 4 ; Table IV ). When 6SHT55 is compared with the corresponding hydroxamate compound with a C 6 acyl chain at the 3-position (TU-521), the phosphinate inhibitor is not quite as effective as the hydroxamate against E. coli LpxC (IC 50,hydrox /IC 50,phos ϭ 0.4). However, when the ratio of these activities against A. aeolicus LpxC is compared, the IC 50,hydrox /IC 50,phos is greater than 20. The fact that both LpxC enzymes are inhibited by the phosphinate-containing inhibitor 6SHT55 suggests that the transition state in LpxC catalysis may be similar to the tetrahedral transition states proposed to occur during hydrolysis of amide bonds catalyzed by thermolysin or carboxypeptidase A (36) .
The phenyloxazolines L-573,655 and LNTI-229 are bactericidal against E. coli, with the best compound, LNTI-229, exhibiting a potency against wild-type E. coli cells comparable with ampicillin ( Fig. 7) (10) . However, the phenyloxazolines are not broadly active against a wide range of Gram-negative bacteria; for instance, no antibacterial activity is detected against the common human pathogen P. aeruginosa with even the most potent phenyloxazoline (10) . One reason for this lack of activity is suggested by the complete failure of the phenyloxazolines to inhibit LpxC of A. aeolicus. Although the substrate specificity of LpxC is conserved in diverse bacteria, the ability of the phenyloxazolines to inhibit LpxC is not. Additional support for this hypothesis comes from the observation that LNTI-229 is ϳ20-fold less potent in vitro against P. aeruginosa LpxC than against E. coli LpxC (data not shown).
Despite the fact that their activity in vitro against E. coli LpxC approaches that of LNTI-229 (Table IV) , the substrate analog inhibitors of LpxC (Fig. 4) are not very active as antibacterial agents against wild-type strains of E. coli (data not shown). This finding suggests that these compounds are prevented from entering cells, are metabolized, or are extruded. The antibiotic activity of the inhibitors shown in Fig. 4 could potentially be increased by replacing the acyl chain with alternative hydrophobic groups, and/or deleting some hydroxyl moieties on the tetrahydropyran ring. Despite their weak bactericidal activity against E. coli compared with the phenyloxazolinebased compounds, the substrate analog inhibitors (Fig. 4) are nonetheless the first compounds that inhibit the LpxCs of the most diverse Gram-negative bacteria, supporting the idea that LpxCs have retained common mechanistic and structural features. Structural characterization of LpxCs by x-ray crystallography or NMR spectroscopy should therefore facilitate the design of even more potent and broad-spectrum deacetylase inhibitors useful as antibiotics. We propose that inhibitors of the lpxC-encoded deacetylase that display antibiotic activity be designated "deacetylins."
